Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
Clinical trial NCT03238781 · COMPLETED
Trial details
- NCT number
- NCT03238781
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-06
- Primary completion
- 2018-10-16
- Enrollment
- 343
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.